CO4920243A1 - Bis-acridinas sustituidas y compuestos afines como ligandos del receptor ccrs, agentes antiinflamatorios y agentes antiviricos - Google Patents
Bis-acridinas sustituidas y compuestos afines como ligandos del receptor ccrs, agentes antiinflamatorios y agentes antiviricosInfo
- Publication number
- CO4920243A1 CO4920243A1 CO98000422A CO98000422A CO4920243A1 CO 4920243 A1 CO4920243 A1 CO 4920243A1 CO 98000422 A CO98000422 A CO 98000422A CO 98000422 A CO98000422 A CO 98000422A CO 4920243 A1 CO4920243 A1 CO 4920243A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- independently
- agents
- cycloalkyl
- 4alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
- C07D219/12—Amino-alkylamino radicals attached in position 9
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3514897P | 1997-01-08 | 1997-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4920243A1 true CO4920243A1 (es) | 2000-05-29 |
Family
ID=21880954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98000422A CO4920243A1 (es) | 1997-01-08 | 1998-01-07 | Bis-acridinas sustituidas y compuestos afines como ligandos del receptor ccrs, agentes antiinflamatorios y agentes antiviricos |
Country Status (9)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
| US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
| US6514987B1 (en) * | 1997-01-06 | 2003-02-04 | Cerus Corporation | Frangible compounds for pathogen inactivation |
| ZA985542B (en) | 1997-07-03 | 1999-04-07 | Smithkline Beecham Corp | Substituted benzanilides as CCR5 receptor ligands antiinflammatory agents and antiviral agents |
| EP1535909A3 (en) | 1997-11-18 | 2005-07-13 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
| DE60023878T2 (de) | 1999-05-18 | 2006-07-20 | Teijin Ltd. | Heilmittel und vorbeugung für mit chemokinen verbundenen erkrankungen |
| CA2412345A1 (en) * | 1999-06-16 | 2000-12-21 | University Of Iowa Research Foundation | Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| AU779610B2 (en) | 1999-08-04 | 2005-02-03 | Teijin Limited | Cyclic amine CCR3 antagonists |
| WO2001042208A1 (fr) * | 1999-12-08 | 2001-06-14 | Teijin Limited | Antagonistes du recepteur ccr5 de la cycloamine |
| US6410566B1 (en) | 2000-05-16 | 2002-06-25 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
| US7160896B2 (en) | 2000-07-07 | 2007-01-09 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
| US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
| AU2003207646C1 (en) * | 2002-01-22 | 2008-09-18 | Vanderbilt University | Treating stress response with chemokine receptor CCR5 modulators |
| AU2003261103A1 (en) * | 2002-07-02 | 2004-01-23 | Uab Research Foundation | Compounds promoting delivery of genes |
| WO2005105841A2 (en) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
| WO2008030853A2 (en) * | 2006-09-06 | 2008-03-13 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
| US20140271680A1 (en) | 2011-08-12 | 2014-09-18 | Universite Paris-Est Creteil Val De Marne | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| US10149830B2 (en) | 2016-06-03 | 2018-12-11 | Cushing Academy | Pharmaceutical agents and methods relating thereto |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2503899A (en) * | 1945-08-29 | 1950-04-11 | Dow Chemical Co | Diacridyl diamine derivatives |
| FR2314165A1 (fr) * | 1975-06-13 | 1977-01-07 | Anvar | Nouveaux bis (anthryl-9) alcanes et leur preparation |
| FR2588259B1 (fr) * | 1985-10-04 | 1988-01-22 | Aix Marseille Universite | Bis-acridiniques monopontes et bis-acridiniques bipontes |
| JPH0688924B2 (ja) * | 1986-05-28 | 1994-11-09 | ダイセル化学工業株式会社 | 光記憶材料 |
| DE4014421A1 (de) * | 1990-05-05 | 1991-11-07 | Merck Patent Gmbh | Aminosaeurederivate |
| JPH04226467A (ja) * | 1990-09-13 | 1992-08-17 | Ricoh Co Ltd | 電子写真感光体の疲労回復方法 |
| EP0570594B1 (en) * | 1991-12-10 | 1997-07-30 | Shionogi & Co., Ltd. | Hydroxamic acid derivative based on aromatic sulfonamide |
| DE4405378A1 (de) * | 1994-02-19 | 1995-08-24 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
-
1998
- 1998-01-05 AR ARP980100032A patent/AR011057A1/es unknown
- 1998-01-07 ZA ZA9895A patent/ZA9895B/xx unknown
- 1998-01-07 CO CO98000422A patent/CO4920243A1/es unknown
- 1998-01-08 EP EP98903437A patent/EP0979078A4/en not_active Withdrawn
- 1998-01-08 CA CA002276525A patent/CA2276525A1/en not_active Abandoned
- 1998-01-08 JP JP53117498A patent/JP2001509152A/ja active Pending
- 1998-01-08 WO PCT/US1998/000489 patent/WO1998030218A1/en not_active Application Discontinuation
- 1998-01-08 AU AU60208/98A patent/AU6020898A/en not_active Abandoned
- 1998-01-08 US US09/341,171 patent/US6242459B1/en not_active Expired - Fee Related
-
2001
- 2001-04-11 US US09/833,044 patent/US20010031763A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20010031763A1 (en) | 2001-10-18 |
| JP2001509152A (ja) | 2001-07-10 |
| US6242459B1 (en) | 2001-06-05 |
| AU6020898A (en) | 1998-08-03 |
| EP0979078A4 (en) | 2000-06-21 |
| ZA9895B (en) | 1998-07-08 |
| WO1998030218A1 (en) | 1998-07-16 |
| CA2276525A1 (en) | 1998-07-16 |
| EP0979078A1 (en) | 2000-02-16 |
| AR011057A1 (es) | 2000-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4920243A1 (es) | Bis-acridinas sustituidas y compuestos afines como ligandos del receptor ccrs, agentes antiinflamatorios y agentes antiviricos | |
| ECSP066312A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| EA200000391A1 (ru) | Производные тиенопиримидина и тиенопиридина, полезные в качестве противораковых агентов | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| EA200200571A1 (ru) | Новая композиция и ее применение | |
| NO941647D0 (no) | Heteroarylpiperidiner, pyrrolidiner og piperaziner og deres anvendelse som antipsykotika og analgetika | |
| ECSP066313A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| ECSP066315A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| SE9701144D0 (sv) | Novel compounds, their use and preparation | |
| BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
| DE69027865T2 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
| ECSP066314A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| NO953093L (no) | Forbindelser med både sterk kalsiumantagonist- og antioksidantvirkning, samt anvendelse derav som cellebeskyttende midler | |
| ES2061463T3 (es) | Compuestos de piperidina y su preparacion y uso. | |
| EA199700450A1 (ru) | Способы подавления миграции сосудистых гладкомышечных клеток | |
| ES2155093T3 (es) | Nuevos inhibidores de la uridina fosforilasa (urdpasa) y de la dihidrouracil deshidrogenasa (dhudasa). | |
| MX9205123A (es) | Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios. | |
| CO5160295A1 (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos cionalmente un ssri | |
| NO912414D0 (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
| AR042687A1 (es) | Pirimidinas sustituidas y su uso como inhibidores de mmp-13 selectivos. procedimiento de preparacion y composiciones farmaceuticas. | |
| AR007052A1 (es) | Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende | |
| TW200718423A (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and pharmaceutical composition thereof | |
| AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
| IT1233198B (it) | Derivati di benzilidene ciclanoni,procedimento per la loro preparazione, loro impiego come agenti anti- ossidanti, composizioni cosmetiche e farmaceutiche che li contengono | |
| SE8402199L (sv) | Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist |